Thermo Fisher Scientific (TMO) reported an earnings beat for its 4th quarter, ending 12/31/2022. Earnings per share came in at $5.40, versus the expected $5.20.
The reported revenue of $11.45 billion represents growth of 7.24% compared to the previous quarter, and growth of 6.99% compared to the same period last year.
For the 1st quarter, analysts project earnings of $5.26 per share.
Often, earnings announcements affect a stock’s price. See a history of earnings-related price changes for TMO stock.
What’s Next for Thermo Fisher Scientific, Post-Earnings?
According to TipRanks, the average analyst consensus on TMO stock is a Moderate Buy. This consensus is based on 10 analyst ratings made in the past 3 months. Thermo Fisher Scientific’s average price target of $635.10 implies upside potential of 8.13% from current levels.
See our Earnings Calendar for a full list of this week’s earnings releases.
Bottom Line
An earnings beat can signify positive movement ahead for a stock’s price. Currently, TMO price is $587.36, indicating a 5-day rise of 2.39%.
About Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services segments. The company was founded on October 11, 1960 and is headquartered in Waltham, MA..
Learn more about TMO financials here
